Search

Your search keyword '"Joshua M. Diamond"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Joshua M. Diamond" Remove constraint Author: "Joshua M. Diamond"
225 results on '"Joshua M. Diamond"'

Search Results

151. Fluorescence Competition and Optical Melting Measurements of RNA Three-Way Multibranch Loops Provide a Revised Model for Thermodynamic Parameters†

152. The contribution of airway and lung tissue ischemia to primary graft dysfunction

153. Obesity-driven IL-18 inhibits the suppressive function of FOXP3+ T-regulatory (Treg) cells

154. Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation

155. Organ Sequence Number (SN) is Not a Proxy for Organ Quality

156. A mathematical model describes Drosophila sleep behavior in w1118 controls and in a hyposomnolent insomniac line

157. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia

158. Soluble CD14 and LBP as Markers for Primary Graft Dysfunction

159. Massive donor transfusion potentially increases recipient mortality after lung transplantation

160. Lung Allocation Score Implementation Narrowed Racial/Ethnic Disparities in Adult Lung Transplantation Outcomes

161. Gene Set Enrichment Analysis Identifies a Potential Link Between Smoking and Upregulation of Olfactory Receptor and Cytokine Enrichment Pathways

162. Lung Transplant Experience with Public Health Services Increased Risk Donors: Recipient Outcomes and Incidence of Transmission and Conversion

163. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing

164. Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation

165. Cognitive function, mental health, and health-related quality of life after lung transplantation

166. Thermodynamics of Three-Way Multibranch Loops in RNA

167. Mycobacterium Abscessus in Lung Transplant Recipients: The University of Pennsylvania Experience

168. PGD Is Associated With Persistent Differential Gene Expression After Lung Transplantation

169. Impact of Diastolic Dysfunction on Primary Graft Dysfunction (PGD) After Lung Transplantation

170. Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension

171. Peripheral Blood Gene Expression Identifies Damage-Associated Innate Immune Pathways in Patients With Primary Graft Dysfunction After Lung Transplantation

172. From Research to Clinical Practice. Cognitive Trajectory after Lung Transplantation

173. Role of innate immunity in primary graft dysfunction after lung transplantation

174. Donor age and early graft failure after lung transplantation: a cohort study

175. Should we reconsider lung transplantation through uncontrolled donation after circulatory death?

176. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation

177. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation

178. Latent Class Analysis Identifies Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation

179. Clinical risk factors for primary graft dysfunction after lung transplantation

180. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation

181. Massive Donor Transfusion Increases Recipient Early Mortality after Lung Transplantation

182. Redefining Primary Graft Dysfunction after Lung Transplantation

183. Plasma RIP3 Is Decreased in PGD after Lung Transplantation

184. Lung-enriched Organisms and Aberrant Bacterial and Fungal Respiratory Microbiota after Lung Transplant

185. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation

186. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation

187. Association Of Angiopoietin-2 Plasma Levels And Development Of Primary Graft Dysfunction Following Lung Transplantation

188. Variation In Oxidant Stress Genes In Recipients And Donors Is Associated With The Development Of Primary Graft Dysfunction (PGD) After Lung Transplantation

189. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts

190. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis

191. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study

192. Elevated Monocyte Chemotactic Protein-1 (MCP-1) Is Associated With Primary Graft Dysfunction Following Lung Transplantation

193. Elevated Plasma Clara Cell Secretory Protein Concentration is Associated with High-Grade Primary Graft Dysfunction

194. Mechanical Ventilation after Lung Transplantation. It’s Time for a Trial

195. Candidate Gene Association Study in BOS

196. Identification of a High-Risk Group for Development of BOS Using Latent Class Analysis

197. Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking

198. Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated With High-Grade Primary Graft Dysfunction

200. Lung transplantation for chronic obstructive pulmonary disease: special considerations

Catalog

Books, media, physical & digital resources